Breast cancer in elderly women. Optimizing the treatment
Akt plays an important role in breast cancer cell chemotaxis to CXCL12
Effects of IL-12 gene therapy on spontaneous transgenic and transplanted breast tumors
Colocalisation of predicted exonic splicing enhancers in BRCA2 with reported sequence variants
Consensus genes of the literature to predict breast cancer recurrence
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis
Extracellular matrix, Rac1 signaling, and estrogen-induced proliferation in MCF-7 breast cancer cells
Antibodies to 46-kDa retinal antigen in a patient with breast carcinoma and cancer-associated retinopathy
Differential gene expression profile in breast cancer-derived stromal fibroblasts
Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice
Central carbon metabolism in the progression of mammary carcinoma
A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancer
The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy
Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial
I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer
Does high surgeon and hospital surgical volume raise the five-year survival ratefor breast cancer? A population-based study
Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged ≤55 years
Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans
G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history
CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk
Standardization of pathologic complete response rates in breast cancer treatment